"I thought it was because a freezer in the lab was warming up or it was a wrong number," he said. Even after I got over "being mad at the phone to ring," added Dr. Rice, a self-described night owl, added, "My first impression was that this had to be a crank call."
Dr. Cameron, a frequent contributor to Dr. Rice, described him as welcoming, generous, and a dedicated and productive mentor. "His laboratory really populated the flavivirus field," said Dr. Cameron, referring to the virus family, which also includes the hepatitis C virus. "Formally, I wasn't an intern, but I feel like I was adopted by him early on."
Dr. Born in the UK, Houghton is a Canada Excellence Research Chair in Virology and Li Ka Shing Professor of Virology at the University of Alberta. He is also the director of the Li Ka Shing Institute of Applied Virology at the university. He has his Ph.D. from King & # 39; s College London in 1977.
Shortly after the award was announced, scientists discovered on social media that Dr. Houghton refused to accept the Canada Gairdner International Award in 2013, which he criticized for hitting his colleagues Dr. Choo and Dr. Kuo not involved. In a press conference on Monday, Dr. However, Houghton said it was "really too presumptuous" to turn down a Nobel Prize and highlighted the contributions of his colleagues with whom he is currently developing a hepatitis C vaccine.
"Great science is often a group of people," he said. "In the future we have to take that into account somehow."
The Nobel Prizes for Science have long been criticized for failing to improve the performance of women and people of color in the scientific community.
"While I am always pleased that virologists are recognized for their excellent work, the Nobel Committee continues its efforts to recognize the achievements of white men," said Dr. Rasmussen. "I really wish the Nobel Committee would consider recognizing substantial achievements by women or people of color as well as by scientists outside North America or Europe."